A Study Comparing Dosing Regimens and Efficacy of Subcutaneous to Intravenous Azacitidine (AZA) for the Treatment of Myelodysplastic Syndromes (MDS).
暂无分享,去创建一个
D. Donley | J. Maciejewski | M. Sekeres | J. Malone | A. List | R. Komrokji | M. Narang | D. Grinblatt | Kristen A. Sullivan | J. Baker | D. A. Sweet | D. Sweet